Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance" [J. Cardiol. 56 (2010) 111–117]. Issue 3 (March 2015)